The future of tyrosine kinase inhibitors for melanoma and open questions

Axel Hauschild, MD, PhD of University Hospital Schleswig-Holstein, Kiel, Germany, gives an overview of his talk on the future of tyrosine kinase inhibiton for melanoma at the 2016 World Congress on Ca... Author: VJOncology Added: 09/12/2016
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts